SCN5A-related cardiomyopathies encompass a broad clinical spectrum and are often preceded or accompanied by conduction disease, as well as atrial and ventricular arrhythmias, such as PVCs in the context of MEPPC. This evidence concerns the gene SCN5A and cardiomyopathy.